Mehmet Mutlu Kıdı

12PUBLICATIONS

84CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsComputational linguisticsPredictive and prognostic markersLiquid biopsies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jul 15, 2026

Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.

|Jun 26, 2026

Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) Study.

|Jun 26, 2026

Efficacy and Tolerability of Pazopanib in Elderly Patients with Advanced Soft Tissue Sarcoma: A Multicentre Real-World Study from Turkey.

|Jun 26, 2026

Feasibility and Concordance of a Large Language Model (ChatGPT-5) as a Clinical Decision Support Tool in Gynecologic Oncology Tumor Boards: A Blinded, Multi-Observer Study.

|Jun 12, 2026

Impact of Anatomical Localization on Systemic Inflammatory Markers and Immune Checkpoint CD47 in Desmoid Tumors.

|May 08, 2026

Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.

Pageof 2

Frequent Collaborators

Ertuğrul Bayram

Mahmut Buyuksimsek

Sedat Biter

Hatice Asoglu

Ali Ogul

Semra Paydas

Deniz Can Guven

Ayşe Nuransoy Cengiz

Emel Mutlu Ozkan

Metin Ozkan

Frequent Collaborators

Ertuğrul Bayram

Mahmut Buyuksimsek

Sedat Biter

Hatice Asoglu